METASTATIC RENAL CELL CARCINOMA
Clinical trials for METASTATIC RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune therapy duo battles Tough-to-Treat kidney cancer
Disease control CompletedThis study tested whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) works better than standard treatments for people with a specific, hard-to-treat type of advanced kidney cancer that has spread. It involved 316 adults with previously untreated, advanced…
Matched conditions: METASTATIC RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Goethe University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Major cancer trial questions need for surgery
Disease control CompletedThis study aimed to find out if patients with kidney cancer that has spread (metastasized) live longer by having their kidney removed first, followed by the drug sunitinib, compared to just taking the drug alone. It involved 452 adults with a specific type of advanced kidney canc…
Matched conditions: METASTATIC RENAL CELL CARCINOMA
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Real-World data reveals how kidney cancer patients fare on modern immunotherapies
Knowledge-focused CompletedThis study analyzed existing medical records to understand how well different immunotherapy combinations work for people with advanced kidney cancer that has spread. Researchers looked at data from 494 patients who received these modern treatments first, followed by other therapi…
Matched conditions: METASTATIC RENAL CELL CARCINOMA
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:09 UTC